Should we still use azithromycin for gonorrhoea treatment?

Mensforth, Sarah and Ross, Jonathan D C (2019) Should we still use azithromycin for gonorrhoea treatment? Sexual health, 16 (5). pp. 442-448. ISSN 1449-8987. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs.

Full text not available from this repository.
Official URL: https://www.publish.csiro.au/SH/SH19016

Abstract

This review presents the evidence for azithromycin in the treatment of gonorrhoea, both as monotherapy and as a component of dual therapy. Uncertainties are explored regarding the efficacy of a dual treatment strategy, combining ceftriaxone and azithromycin, in the context of resistance trends and extra-genital infections. The association between microbiological testing and clinical outcome for the individual patient, and the effect of azithromycin use on other sexually transmissible infections, are considered. Finally, in the absence of imminent new antimicrobials, optimising the dose of azithromycin while maintaining tolerability is discussed.

Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs.
Subjects: QV Pharmacology
WC Communicabable diseases
Divisions: Ambulatory Care
Related URLs:
Depositing User: Mrs Noomi Tyholdt-Pidgley
Date Deposited: 08 Jan 2021 15:15
Last Modified: 08 Jan 2021 15:15
URI: http://www.repository.uhblibrary.co.uk/id/eprint/3807

Actions (login required)

View Item View Item